Kay Seden

Summary

Affiliation: University of Liverpool
Country: UK

Publications

  1. doi request reprint Global patient safety and antiretroviral drug-drug interactions in the resource-limited setting
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    J Antimicrob Chemother 68:1-3. 2013
  2. doi request reprint Patients accessing HIV treatment via sexual health services: what are the risks of the dual case-note system?
    K Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Int J STD AIDS 23:99-104. 2012
  3. doi request reprint Grapefruit-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Drugs 70:2373-407. 2010
  4. doi request reprint Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Curr Opin HIV AIDS 6:514-26. 2011
  5. doi request reprint New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, and Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
    J Antimicrob Chemother 65:1079-85. 2010
  6. doi request reprint Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach
    Marco Siccardi
    Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK
    Clin Pharmacokinet 52:583-92. 2013
  7. doi request reprint Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK
    J Antimicrob Chemother 64:5-8. 2009

Detail Information

Publications7

  1. doi request reprint Global patient safety and antiretroviral drug-drug interactions in the resource-limited setting
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    J Antimicrob Chemother 68:1-3. 2013
    ....
  2. doi request reprint Patients accessing HIV treatment via sexual health services: what are the risks of the dual case-note system?
    K Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Int J STD AIDS 23:99-104. 2012
    ..We recommend that hospitals that continue to operate this system urgently consider amalgamation of HIV care records into hospital case sheets, in line with current national standards...
  3. doi request reprint Grapefruit-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Drugs 70:2373-407. 2010
    ..The aim of this review is to outline the mechanisms of grapefruit-drug interactions and present a comprehensive summary of those agents affected and whether they are likely to be of clinical relevance...
  4. doi request reprint Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Curr Opin HIV AIDS 6:514-26. 2011
    ..Potential for DDIs with the DAAs in clinical development and the mechanisms of interaction are also discussed...
  5. doi request reprint New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, and Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
    J Antimicrob Chemother 65:1079-85. 2010
    ..Therapeutic drug monitoring is likely to play a role in the clinical management of such interactions...
  6. doi request reprint Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach
    Marco Siccardi
    Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK
    Clin Pharmacokinet 52:583-92. 2013
    ....
  7. doi request reprint Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK
    J Antimicrob Chemother 64:5-8. 2009
    ....